Section A. Incidence of reported ESRD. Vol 3 esrd. pg 429. A tables

Transcription

1 Section A Incidence of reported ESRD Vol 3 esrd pg 429

2 Table A Incident counts of reported ESRD: all patients by age, gender, race, ethnicity, & primary diagnosis Table A Incident rates of reported ESRD per million population, by age, gender, race, ethnicity, & primary diagnosis Table A.3 43 Incident rates of reported diabetic ESRD per million population, by age, gender, race, & ethnicity Table A Incident counts of reported ESRD patients, combined by age & primary diagnosis Table A. 438 Incident rates of reported ESRD, combined per million population, by age & primary diagnosis Table A Mean age at start of ESRD therapy by age, gender, race, ethnicity, primary diagnosis, & location Table A Incidence of reported ESRD, by primary diagnosis, combined by detailed primary diagnosis Table A Incident counts of reported ESRD patients, by diabetic status & state/territory Table A Incident rates of reported ESRD, by diabetic status & state, adjusted per million population Table A Incident counts of reported ESRD patients, by diabetic status & ESRD network Table A Incident rates of reported ESRD, by diabetic status & ESRD network, adjusted per million population Throughout this reference section The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. The age of the incident patient is determined as of the date of ESRD initiation. Adjusted rates use the 200 ESRD cohort as reference (represented by outlined columns in tables). pg 430 The following symbols are used throughout this reference section CMS began collecting Hispanic ethnicity data in April 199; cells for years prior to 1996 have therefore been left blank. * Values for cells with ten or fewer patients are suppressed.. Zero values in this cell. Data for some early years are omitted from the printed tables; complete data are available on our website, at

3 Table A.1 Incident counts of reported ESRD: all patients by by age, age, gender, gender, race, race, ethnicity, & primary primary diagnosis ,36 2,08 2,63 2,693 2,709 2,709 2,81 2,48 2,636 2,736 2,79 2, ,220 3,306 4,88,749,823,74,797,734,799,898 6,017, ,441 3,689 6,276 8,98 10,989 11,09 11,327 11,627 11,942 12,116 12,640 12, ,70,00 8,39 11,9 16,880 17,769 18,222 19,160 19,80 20,668 21,90 22, ,133 3,90 6,138 8,003 10,078 10,478 10,84 11,267 11,64 11,940 12,418 12, ,183 3,928 7,244 9,313 11,02 11,878 11,803 12,171 12,310 12,228 12,711 12, ,26,78 10,874 16,83 23,961 24,841 24,939 24,949 24,938 2,067 2,3 24, ,02 2,397 4,19 7,4 7,770 8,749 8,910 9,20 9,738 9,861 9, ,78 3,900 4,288 4,684,00,240,23,814 6,124 Unknown. * * * * * * * * * * * ,087 1,16 1,230 1,246 1,284 1,306 1,30 1,316 1,300 1, ,869 7,131 10,637 12,37 13,269 13,171 13,120 13,134 13,401 13,742 13,99 13, ,211 11,399 17,66 24,848 33,210 34,98 3,391 37,202 38,471 39,616 41,789 42, ,790 7,411 13,09 18,686 23,890 24,764 24,10 24,622 24,871 24,770 2,33 2, ,32 3,687 7,968 13,14 22,928 24,013 2,66 26,413 26,867 27,786 28,388 28,234 Unknown. * * *.... *. * * Male 10,026 16,60 27,303 37,13 0,96 2,96 4,321,62 7,973 9,0 62,024 62,239 Female 7,91 13,971 23,6 33,22 43,929 4,196 4,649 47,04 46,989 47,677 48,983 48,78 Unknown * *. * *.. *. * * * White 12,64 20,792 33,820 44,68 61,809 63,919 6,00 66,410 68,469 70,134 73,141 72,668 African American 4,867 8,722 14,99 21,618 26,763 27,80 28,696 29,78 29,383 30,471 31,446 31,61 Native American ,201 1,17 1,147 1,13 1,204 1,222 1,22 1,24 Asian ,29 2,290 3,247 3,440 3,98 3,70 3,887 4,136 4,778,106 Other/unknown ,07 1,43 1,24 1,804 2,019 1, Hispanic 12,4 11,793 12,28 13,32 13,692 13,88 14,784 1,07 Non-Hispanic 81,982 8,999 87,442 89,32 91,270 93,34 96,224 9,943 Diabetes 2,689 8,703 18,10 29,326 42,427 44,140 44,447 4,644 46,71 47,389 49,340 48,871 Hypertension 3,161 8,260 1,386 18,826 2,061 26,299 27,273 28,2 28,69 29,004 29,773 30,67 Glomerulonephritis 2,800,108 7,082 8,307 8,681 8,628 8,733 8,439 8,600 8,193 8,004 7,71 Cystic kidney 772 1,226 1,80 1,932 2,190 2,268 2,20 2,304 2,340 2,21 2,69 2,633 Other urologic 476 1,178 1,310 2,00 2,740 2,773 2,933 2,820 2,877 2,173 1,674 1,4 Other cause 1,828 3,4 4,860 7,139 9,119 9,327 9,948 10,202 10,82 12,364 13,787 14,141 Unknown cause 1,600 1,2 1,933 2,494 3,791 4,026 3,972 4,074 4,138 4,677 4,846 4,63 Missing disease 4, U.S. 17,611 29,948 49,864 69,382 93,21 96,424 98,27 101, ,219 10, , ,109 U.S territories * Puerto Rico ,103 1,174 1,213 1,289 1,294 1,237 1,332 1,30 Foreign * Unknown All 17,978 30,33 0,89 70,393 94,27 97,792 99, , , , , ,000 Section A 2009 USRDS Annual Data Report 4 Incidence of reported ESRD on our website & cd Incident counts of reported ESRD, by primary diagnosis, (A.1.1-4), patients residing in Puerto Rico & U.S. territories (A.a). Percent decrease in incident counts of ESRD patients, after dropping patients with other & unknwon race (A.b). Vol 3 esrd pg 431

4 Table A.1 (continued) Incident counts of reported ESRD: patients: all patients: U.S. U.S. only, only, with with unknowns unknowns dropped dropped by by age, age, gender, gender, race, race, ethnicity, & primary primary diagnosis ,483 2,031 2,64 2,621 2,73 2,91 2,431 2,400 2,463 2,96 2,682 2, ,14 3,231 4,79,618,640,4,98,467,493,736,888, ,39 3,91 6,086 8,736 10,664 10,773 10,980 11,223 11,481 11,76 12,31 12, ,619,36 8,107 11,66 16,310 17,181 17,62 18,48 19,132 20,071 21,492 21, ,044 3,89,986 7,780 9,731 10,160 10,22 10,86 11,236 11,63 12,146 12, ,112 3,87 7,12 9,072 11,202 11,7 11,49 11,820 11,97 11,929 12,473 12, ,416,701 10,736 16,330 23,30 24,374 24,478 24,426 24,4 24,642 2,19 24, ,012 2,370 4,098 7,33 7,673 8,630 8,769 9,111 9,60 9,747 9, ,78 3,860 4,242 4,622 4,929,168,467,73 6, ,049 1,122 1,173 1,183 1,212 1,211 1,242 1,23 1,240 1, ,701 6,94 10,348 12,230 12,802 12,724 12,626 12,4 12,720 13,289 13,671 13, ,949 11,123 17,14 24,091 32,116 33,26 34,287 3,89 37,08 38,14 40,888 41, ,644 7,290 13,338 18,303 23,33 24,204 23,93 23,981 24,278 24,233 2,110 24, ,30 3,631 7,869 12,9 22,610 23,660 2,290 2,963 26,431 27,410 28,08 27,917 Male 9,68 16,177 26,670 36,167 49,148 1,09 2,760 3,827 6,114 8,07 60,82 61,001 Female 7,677 13,681 23,088 32,34 42,888 44,202 44,90 4,741 4,642 46,624 48,142 47,890 White 12,293 20,369 33,134 44,09 61,033 63,112 64,187 6,39 67,8 69,146 71,961 71,43 African American 4,814 8,614 14,829 21,09 26,660 27,679 28,47 29,428 29,239 30,306 31,220 31,37 Native American ,201 1,17 1,147 1,133 1,204 1,218 1,203 1,23 Asian ,196 2,213 3,142 3,331 3,469 3,612 3,7 4,011 4,83 4,846 Hispanic 10,721 9,918 10,43 11,093 11,478 12,132 13,418 13,678 Non-Hispanic 81,31 8,379 86,807 88,47 90,278 92,49 9,49 9,213 Diabetes 2,90 8,10 17,707 28,49 41,097 42,747 43,00 44,034 4,126 46,120 48,284 47,778 Hypertension 3,093 8,137 1,19 18,24 24,669 2,874 26,833 27,998 28,162 28,612 29,33 30,402 Glomerulonephritis 2,724 4,993 6,909 8,122 8,42 8,384 8,462 8,160 8,29 8,003 7,871 7,436 Cystic Kidney 77 1,20 1,1 1,900 2,13 2,21 2,197 2,248 2,282 2,477 2,629 2,601 Other urologic 460 1,10 1,261 1,983 2,671 2,71 2,867 2,76 2,819 2,124 1,638 1,19 Other cause 1,783 3,03 4,796 7,01 8,910 9,149 9,740 9,988 10,618 12,17 13,63 13,993 Unknown cause 1,13 1,489 1,863 2,420 3,678 3,916 3,880 3,934 3,997 4,612 4,809 4,600 Missing disease 4, All 17,33 29,88 49,78 68,701 92,036 9,297 97,30 99,68 101,76 104, , ,891 Patients dropped ,101 1,692 2,491 2,49 2,620 3,109 3,206 2,49 2,041 2,109 pg 432 U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded.

5 Table A.2 Incident rates of reported ESRD per per million population, by by age, gender, race, ethnicity, & primary diagnosis UNADJUSTED , , , , , , , , , , ,01.4 1,1.6 1,19.7 1,34.6 1,47.1 1,81.7 1, , , ,62.4 1, , , , , , ,04.4 1, ,081. 1, , , , , , , , , , ,33.2 1, , ,47.2 1, ,13.8 1,29.6 1,06.1 Male Female White African American Native American Asian Hispanic Non-Hispanic Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing disease All Section A 2009 USRDS Annual Data Report 4 Incidence of reported ESRD U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded. on our website & cd Incident rates of reported ESRD: diabetes, hypertension, glomerulonephritis, & cystic kidney disease (A.2.1-4). Vol 3 esrd pg 433

6 Table A.2 (continued) Incident rates of reported ESRD per per million population, by by age, gender, race, ethnicity, & primary diagnosis ADJUSTED ,01.7 1,28.0 1, , , , , , , , , , , , , , ,70.6 1, , , , , ,893. 1, , , , ,191. 1,21.2 1,317. 1, , , , , , , ,4.8 1,448. 1,442. 1, , ,44.7 1, ,01.4 1,71.8 1, , , , ,737. 1, ,734.9 Male Female White African American ,010. 1, , , , Native American Asian Hispanic Non-Hispanic Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing disease All pg 434 Rates by age are adjusted for gender & race, rates by gender are adjusted for age & race, rates by race & ethnicity are adjusted for gender & age. U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded.

7 Table A.3 Incident rates of reported diabetic ESRD per per million population, by by age, gender, race, & ethnicity UNADJUSTED * * * * * * * * * * * -9.. *... * * * *. * *. * * * * 0.8 * * * * * * * * * * 0.2 * * Male Female White African American Native American Asian * Hispanic Non-Hispanic All ADJUSTED 0-4. * * * * * * * * * * * -9.. *... * * * *. * *. * * * * 0.8 * * * * * * * * * * 0.2 * * Section A 2009 USRDS Annual Data Report 4 Incidence of reported ESRD Male Female White African American Native American Asian * Hispanic Non-Hispanic All Rates by age are adjusted for gender & race, rates by gender are adjusted for age & race, rates by race & ethnicity are adjusted for gender & age. U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded. Vol 3 esrd pg 43

8 Table A.3 (continued) Incident rates of reported diabetic ESRD:CDC diabetic population per per million population, by by age, gender, race, & ethnicity UNADJUSTED ,207 2,99 2,724 1,873 1,762 1,717 1,762 1,60 1,496 1, ,79 3,084 3,932 3,367 3,232 3,03 2,964 2,826 2,728 2, ,090 2,736 4,20 4,378 4,260 3,992 3,847 3,724 3,604 3, ,96 2,73 3,927 3,891 3,792 3,600 3,98 3,476 3,1 Male 6 1,47 2,848 3,668 3,464 3,322 3,227 3,139 3,149 3,076 3,174 Female 392 1,226 2,3 3,49 3,381 3,314 3,113 3,029 2,784 2,94 2,86 White 406 1,130 2,198 2,974 2,979 2,848 2,660 2,7 2,473 2,384 2,414 African American 72 2,308 4,74,919,912,928,929,727,362,006,013 Other 88 3,70 4,080 3,864 2,77 2,2 2,732 2,916 3,313 2,817 3,067 Hispanic 4,602 4,077 4,070 4,02 3,888 3,9 3,832 Non-Hispanic 3,268 3,220 3,04 2,960 2,841 2,723 2,737 All 464 1,36 2,672 3,4 3,421 3,318 3,170 3,084 2,96 2,830 2,870 ADJUSTED ,014 2,27 2,760 2,862 1,919 1,774 1,700 1,743 1,631 1,448 1, ,670 3,144 3,79 3,318 3,20 3,061 2,91 2,787 2,692 2, ,208 2,86 4,469 4,00 4,33 4,10 3,93 3,89 3,64 3, ,949 2,702 4,141 4,207 4,16 3,967 3,867 3,773 3,814 Male 36 1,624 2,92 3,739 3,609 3,467 3,377 3,24 3,239 3,170 3,280 Female 408 1,36 2,700 3,380 3,307 3,237 3,00 2,99 2,734 2,37 2,0 White 420 1,180 2,214 3,011 2,949 2,801 2,60 2,21 2,428 2,31 2,400 African American 708 2,331 4,902,83 6,198 6,343 6,384 6,022,11,272,327 Other 496 3,067 4,926 4,814 2,926 2,897 3,029 3,221 3,72 2,989 3,189 Hispanic 4,843 4,168 4,296 4,226 4,180 3,878 4,1 Non-Hispanic 3,260 3,209 3,029 2,923 2,809 2,706 2,737 All 472 1,484 2,809 3,4 3,442 3,339 3,196 3,088 2,968 2,830 2,894 pg 436

9 Table A.4 Incident counts of reported ESRD patients, combined by age & primary diagnosis Incident counts of reported ESRD patients, combined Male Female All White Af Am N Am Asian All White Af Am N Am Asian All White Af Am N Am Asian All * * * * * * , , , ,23 1, ,381 1,829 1, ,6 4,32 3, , ,13 4, ,03 3,461 3, ,330 8,96 7, , ,980 8, ,763 7,36 6, ,424 19,34 14, ,49 36, ,126 12, ,618 36,694 14,941 9, ,073 26,393 37,067 22, ,691 63, ,460, ,89 10,290, ,3 23,70 10, ,31 36, ,077 4, ,907 10,868, ,033 24,94 10, ,11 36, ,48 6, ,440 40,09 23,0 9, ,413 34,281 4,963 1, ,83 74, ,320 1, ,81 9,906 2, ,330 23,226 4, ,072 29, , ,198,96 1, ,091 13,833 2, , , ,136 1, ,84 2, , ,30 9, ,063 23,46 8,238 7, ,918 20,768 17, ,932 40, ,694 22, ,049 69,222 29,648 18, ,100 1,419 72,342 41,460 1,690, , ,28 8, ,634 40,002 22,422 10, ,348 34,327 1,707 18, ,982 74, ,447, ,38 44,977 27,813 8, ,96 38,408 6,260 14, ,134 83,38 Diabetes 2,6 18,693 1,193 3,97 76,048 40,811 21,272 1,266 2,78 66,134 93,376 39,96 2,49 6, ,182 Hypertension 31,200 17, ,68 0,690 21,480 14, ,372 37,87 2,680 32, ,07 88,47 Glomerulonephritis 9,886 3, ,28,788 2, ,02 1,674, ,34 23,310 Other cause 29,722 7, ,310 38,887 21,108 7, ,17 29,613 0,830 14, ,467 68,00 All 123,373 47,240 1,839 7, ,883 89,187 4,643 1,817 6, ,66 212,60 92,883 3,66 13, , USRDS Annual Data Report Section A 4 Incidence of reported ESRD U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded. on our website & cd Incident counts of reported ESRD patients for previous three-year period (A.4.1). Incident counts of reported ESRD: by primary diagnosis (A.4.2). Vol 3 esrd pg 437

10 Table A. Incident rates of reported ESRD, combined per per million population, by by age & primary diagnosis Unadjusted rates Rates adjusted for: Male Female Gender Race Gender & White Af Am N Am Asian White Af Am N Am Asian White Af Am N Am Asian Male Female race * * * * * * , , , , ,098 1,416 1, ,441 1, ,768 1, , ,116 3,687 2,133 1, ,043 1, ,360 2,039 1,248 1,48 1,090 1, ,711 4,21 1,811 2,04 1,010 3,6 2,037 1,48 1,366 3,90 1,927 1,79 2,080 1,38 1, ,263 4,333 1,760 2,87 1,064 3,410 1,790 1,8 1,64 3,86 1,784 2,36 2,9 1,419 1, ,73 2, , , ,32 1,166 2, ,83 1,90 8 1, , , , ,292 3,870 1,94 1, ,213 2,037 1,133 1,084 3,61 1,978 1,421 1,679 1,200 1, ,996 4,023 1,687 2, ,16 1,428 1,699 1,441 3,478 1,472 2,068 2,20 1,24 1,740 Diabetes Hypertension Glomerulonephritis Other cause All All (age adjusted) 3 1, , pg 438 on our website & cd Incident rates of reported ESRD for previous three-year period (A..1). Incident rates of reported ESRD: by primary diagnosis (A..2).

11 Table A.6 Mean age at start of ESRD therapy by by age, age, gender, race, ethnicity, primary diagnosis, & location Male Female Unknown White African American Native American Asian Other/unknown Hispanic Non-Hispanic Diabetes Hypertension Glomerulonephritis Cystic kidney Other urologic Other cause Unknown cause Missing disease U.S U.S. territories Puerto Rico Foreign Unknown All Section A 2009 USRDS Annual Data Report 4 Incidence of reported ESRD Patients with unknown age are excluded. on our website & cd Median age at start of ESRD therapy; incident patients by demographic characteristics & primary diagnosis (A.c). Vol 3 esrd pg 439

12 Table Table A.7 A.7 Incidence of reported ESRD, by primary diagnosis, combined by detailed by primary diagnosis Incidence of reported ESRD, by primary diagnosis, combined Total Percent Median Age Percent Percent % Tx % Died ROW PERCENT patients incident age male White Af Am N Am Asian 1st yr 1st yr All ESRD, (reference) 36, Diabetes 237, Diabetes with renal manifestations, Type 2 216, Diabetes with renal manifestations, Type 1 21, Glomerulonephritis 39, Glomerulonephritis (GN; histologically not examined 1, Focal glomerulosclerosis, focal sclerosing GN 11, Membranous nephropathy 2, Membranoproliferative GN type 1, diffuse MPGN 1, Dense deposit disease, MPGN type IgA nephropathy, Berger's (by immunofluorescence 4, IgM nephropathy (by immunofluorescence) With lesion of rapidly progressive GN 1, Post-infectious GN, SBE Other proliferative GN 1, Secondary GN/vasculitis 11, Lupus erythematosus (SLE nephritis), Henoch-Schonlein syndrome Scleroderma Hemolytic uremic syndrome Polyarteritis Wegener's granulomatosis 1, Nephropathy due to heroin abuse and related drug Other vasculitis and its derivatives 1, Goodpasture's syndrome Secondary GN, other Interstitial nephritis/pyelonephritis 17, Analgesic abuse Radiation nephritis Lead nephropathy Nephropathy caused by other agents 2, Gouty nephropathy Nephrolithiasis Acquired obstructive uropathy, Chronic pyelonephritis, reflux nephropathy 1, Chronic interstitial nephritis 3, Acute interstitial nephritis 1, Urolithiasis Other disorders of calcium metabolism Hypertensive/large vessel disease 146, Unspecified with renal failure 13, Renal artery stenosis 7, Renal artery occlusion 1, Cholesterol emboli, renal emboli 2, Cystic/heriditary/congenital diseases 16, Polycystic kidneys, adult type (dominant) 11, Polycystic, infantile (recessive) Medullary cystic disease, including nephronophthis Tuberous sclerosis Hereditary nephritis, Alport's syndrome Cystinosis Primary oxalosis Fabry's disease Congenital nephrotic syndrome Drash syndrome, mesangial sclerosis Congenital obstruction of ureterpelvic junction Congenital obstruction of uretrovesical junction Other congenital obstructive uropathy 1, Renal hypoplasia, dysplasia, oligonephronia Prune belly syndrome Other (congenital malformation syndromes) pg 440 on our website & cd Incidence of reported ESRD, by primary diagnosis: Hispanic & non-hispanic patients (A.7.1-2). Incidence of reported ESRD: by detailed primary diagnosis, age <20, 20-64, & 6+ (A.7.3-).

13 Table Table A.7 A.7 (continued) Incidence of reported ESRD, by primary diagnosis, combined by detailed by primary diagnosis Incidence of reported ESRD, by primary diagnosis, combined Total Percent Median Age Percent Percent % Tx % Died ROW PERCENT patients incident age male White Af Am N Am Asian 1st yr 1st yr Neoplasms/tumors 12, Renal tumor (malignant) 2, Urinary tract tumor (malignant) Renal tumor (benign) Urinary tract tumor (benign) Renal tumor (unspecified) Urinary tract tumor (unspecified) Lymphoma of kidneys Multiple myeloma, Other immuno prolif. neoplasms (inc. light chain ne Amyloidosis 1, Complications of transplanted organ, unspecified Complications of transplanted kidney Complications of transplanted liver Complications of transplanted heart Complications of transplanted lung Complications of transplanted bone marrow Complications of transplanted pancreas Complications of transplanted intestine * Complications of other specified transplanted organ Miscellaneous conditions 27, Sickle cell disease/anemia Sickle cell trait and other sickle cell (HbS/Hb other) Post-partum renal failure AIDS nephropathy 4, Traumatic or surgical loss of kidney(s) Hepatorenal syndrome 2, Tubular necrosis (no recovery) 13, Other renal disorders 6, Etiology uncertain 22, Missing 4, Section A 2009 USRDS Annual Data Report 4 Incidence of reported ESRD Vol 3 esrd pg 441

14 Table A.7 (continued) Incidence of reported ESRD, by primary diagnosis, combined by detailed primary diagnosis Total Counts Percent COLUMN PERCENT patients White Af Am N Am Asian White Af Am N Am Asian All ESRD, (reference) 36,877 30,822 12,439 6,040 21, Diabetes 237,863 1,301 6,760 4,179 10, Diabetes with renal manifestations, Type 2 216, ,186 60,60 3,920 9, Diabetes with renal manifestations, Type 1 21,187 1,11, Glomerulonephritis 39,189 2,962 9, , Glomerulonephritis (GN; histologically not examined) 1,206 10,089 3, , Focal glomerulosclerosis, focal sclerosing GN 11,94 6,909 4, Membranous nephropathy 2,308 1, Membranoproliferative GN type 1, diffuse MPGN 1,648 1, Dense deposit disease, MPGN type * *.... IgA nephropathy, Berger's (by immunofluorescence) 4,328 3, IgM nephropathy (by immunofluorescence) * With lesion of rapidly progressive GN 1,37 1, Post-infectious GN, SBE Other proliferative GN 1,401 1, Secondary GN/vasculitis 11,69 7,284 3, Lupus erythematosus (SLE nephritis),667 2,31 2, Henoch-Schonlein syndrome * * *.... Scleroderma * Hemolytic uremic syndrome * Polyarteritis * Wegener's granulomatosis 1,639 1, Nephropathy due to heroin abuse and related drugs * * Other vasculitis and its derivatives 1, Goodpasture's syndrome * Secondary GN, other * Interstitial nephritis/pyelonephritis 17,11 14,431 2, Analgesic abuse * Radiation nephritis * Lead nephropathy *.... Nephropathy caused by other agents 2,79 2, Gouty nephropathy * Nephrolithiasis * Acquired obstructive uropathy,090 4, Chronic pyelonephritis, reflux nephropathy 1,82 1, Chronic interstitial nephritis 3,92 3, Acute interstitial nephritis 1, * Urolithiasis Other disorders of calcium metabolism * Hypertensive/large vessel disease 146,78 86,949 2,96 641, Unspecified with renal failure 13,072 76,427 2, , Renal artery stenosis 7,089 6, Renal artery occlusion 1,16 1, * Cholesterol emboli, renal emboli 2,901 2, * Cystic/heriditary/congenital diseases 16,890 13,93 2, Polycystic kidneys, adult type (dominant) 11,948 9,76 1, Polycystic, infantile (recessive) * * Medullary cystic disease, including nephronophthisis * Tuberous sclerosis *.... Hereditary nephritis, Alport's syndrome * Cystinosis * * *.... Primary oxalosis 2 38 * * *.... Fabry's disease *.... Congenital nephrotic syndrome * Drash syndrome, mesangial sclerosis *. *.... Congenital obstruction of ureterpelvic junction * * Congenital obstruction of uretrovesical junction * *.... Other congenital obstructive uropathy 1, Renal hypoplasia, dysplasia, oligonephronia Prune belly syndrome * *.... Other (congenital malformation syndromes) * pg 442

15 Table A.7 (continued) Incidence of reported ESRD, by primary diagnosis, combined by detailed primary diagnosis Total Counts Percent COLUMN PERCENT patients White Af Am N Am Asian White Af Am N Am Asian Neoplasms/tumors 12,870 10,260 2, Renal tumor (malignant) 2,011 1, Urinary tract tumor (malignant) * Renal tumor (benign) *.... Urinary tract tumor (benign) 46 * Renal tumor (unspecified) * * Urinary tract tumor (unspecified) * *.... Lymphoma of kidneys * *.... Multiple myeloma,821 4,422 1, Other immuno prolif. neoplasms (inc. light chain neph.) * * Amyloidosis 1,33 1, * Complications of transplanted organ, unspecified *. *.... Complications of transplanted kidney 79 9 * * Complications of transplanted liver * Complications of transplanted heart * * Complications of transplanted lung *. *.... Complications of transplanted bone marrow 9 0 *. *.... Complications of transplanted pancreas * * *.... Complications of transplanted intestine * * * Complications of other specified transplanted organ *. *.... Miscellaneous conditions 27,47 18,846 7, Sickle cell disease/anemia 499 * 48. * Sickle cell trait and other sickle cell (HbS/Hb other) Post-partum renal failure *.... AIDS nephropathy 4, ,691 * * Traumatic or surgical loss of kidney(s) * Hepatorenal syndrome 2,18 1, Tubular necrosis (no recovery) 13,047 10,613 2, Other renal disorders 6,82,470 1, Etiology uncertain 22,293 16,109 4, , Missing 4,67 2, Section A 2009 USRDS Annual Data Report 4 Incidence of reported ESRD Vol 3 esrd pg 443

16 Table A.8 Incident counts of reported ESRD patients, by diabetic status & state/territory ALL Alabama ,338 1,71 1,829 1,81 1,863 1,914 1,93 2,101 1,989 Alaska * Arizona ,210 1,720 1,80 1,809 1,908 1,98 1,933 2,06 2,03 Arkansas , ,040 1,063 California 1,866 3,327,667 7,878 10,774 11,23 11,761 11,989 12,209 12,226 12,68 13,133 Colorado Connecticut , , Delaware District of Columbia Florida 1,139 1,818 3,116 4,278,848 6,084 6,216 6,374 6,81 6,71 6,92 6,882 Georgia ,01 2,270 3,22 3,301 3,33 3,438 3,322 3,616 3,829 3,83 Hawaii Idaho Illinois 830 1,22 2,300 3,467 4,34 4,44 4,819 4,680 4,690 4,878,009,084 Indiana ,002 1,33 1,927 1,962 2,004 2,032 2,034 2,174 2,301 2,28 Iowa Kansas Kentucky ,229 1,323 1,262 1,334 1,442 1,29 1,491 1,04 Louisiana ,103 1,6 1,981 2,139 2,227 2,320 2,247 2,184 2,17 2,20 Maine Maryland ,066 1,690 2,221 2,243 2,36 2,373 2,411 2,19 2,9 2,409 Massachusetts ,342 1,701 1,671 1,667 1,783 1,783 1,762 1,812 1,77 Michigan 766 1,126 1,800 2,48 3,34 3,6 3,61 3,89 3,778 4,009 3,987 3,90 Minnesota ,100 1,247 1,224 1,179 1,322 1,29 1,07 1,36 Mississippi ,14 1,20 1,326 1,348 1,321 1,13 1,433 1,496 Missouri ,012 1,419 1,888 1,948 1,849 1,996 1,988 1,999 2,0 2,131 Montana Nebraska Nevada New Hampshire New Jersey 81 1,29 1,831 2,6 3,128 3,284 3,301 3,370 3,328 3,48 3,67 3,649 New Mexico New York 1,49 2,376 3,839 4,98 6,496 6,619 6,670 6,819 7,046 7,06 7,282 7,330 North Carolina ,42 2,120 3,083 3,180 3,172 3,272 3,317 3,14 3,47 3,30 North Dakota Ohio 708 1,249 2,236 2,919 4,246 4,271 4,320 4,09 4,472 4,64 4,713 4,829 Oklahoma ,084 1,147 1,131 1,263 1,230 1,213 1,249 1,287 Oregon Pennsylvania 941 1,709 2,687 3,00 4,66 4,40 4,770 4,14 4,801 4,804,14,042 Rhode Island South Carolina ,230 1,628 1,699 1,649 1,847 2,000 1,874 1,891 1,913 South Dakota Tennessee ,078 1,470 1,929 1,900 1,992 2,063 2,124 2,278 2,31 2,421 Texas 1,073 1,943 3,94 4,928 6,983 7,247 7,46 7,902 8,00 8,349 8,871 8,832 Utah Vermont Virginia ,227 1,864 2,283 2,09 2,674 2,674 2,770 2,732 2,970 2,837 Washington ,337 1,311 1,434 1,46 1,446 1,46 1,33 1,78 West Virginia Wisconsin ,039 1,413 1,498 1,88 1,630 1,766 1,740 1,813 1,674 Wyoming American Samoa * * * * * Guam * * Puerto Rico ,103 1,174 1,213 1,289 1,294 1,237 1,332 1,30 Saipan. * * * Virgin Islands * Foreign * Unknown pg 444 All 17,978 30,33 0,89 70,393 94,27 97,792 99, , , , , ,000 on our website & cd Incident counts of reported ESRD patients, by diabetic status & state: U.S. only, with unknowns dropped (A.8.1).

17 Table A.8 (continued) Incident counts of reported ESRD patients, by diabetic status & state/territory DIABETIC Alabama Alaska * * Arizona , ,03 1,02 Arkansas * California 213 1,041 2,090 3,373,174,233,490,47,738,661,803 6,061 Colorado Connecticut Delaware * District of Columbia * Florida ,21 2,368 2,33 2,491 2,633 2,702 2,771 2,897 2,873 Georgia ,378 1,399 1,474 1,466 1,432 1,490 1,667 1,9 Hawaii Idaho * Illinois ,317 1,774 1,848 1,922 1,887 1,876 2,00 1,971 1,97 Indiana Iowa Kansas Kentucky Louisiana , Maine * Maryland Massachusetts Michigan ,041 1,04 1,641 1,82 1,63 1,63 1,668 1,673 1,629 Minnesota Mississippi Missouri Montana * Nebraska Nevada New Hampshire * New Jersey ,030 1,327 1,343 1,37 1,364 1,373 1,46 1,01 1,8 New Mexico New York ,246 1,901 2,699 2,837 2,817 2,83 2,938 2,891 3,034 3,09 North Carolina ,362 1,387 1,3 1,446 1,22 1,96 1, 1,48 North Dakota * Ohio ,287 2,006 2,042 1,988 2,067 2,112 2,20 2,12 2,134 Oklahoma Oregon Pennsylvania ,443 1,960 2,011 2,00 1,924 2,03 2,004 2,201 2,149 Rhode Island * South Carolina South Dakota * Tennessee ,00 1,03 Texas ,3 2,41 3,702 3,792 4,014 4,181 4,289 4,412 4,866 4,668 Utah Vermont * Virginia ,001 1,147 1,172 1,128 1,200 1,203 1,268 1,233 Washington West Virginia Wisconsin Wyoming * Section A 2009 USRDS Annual Data Report 4 Incidence of reported ESRD American Samoa. * * * * Guam * * Puerto Rico Saipan.. * * 14 * Virgin Islands. * * Foreign. * * * * * 13 1 * * 13 * Unknown * * * *. * * * * * All 2,689 8,703 18,10 29,326 42,427 44,140 44,447 4,644 46,71 47,389 49,340 48,871 Vol 3 esrd pg 44

18 Table A.8 (continued) Incident counts of reported ESRD patients, by diabetic status & state/territory NON-DIABETIC Alabama ,03 1,040 1,064 1,110 1,184 1,090 Alaska * Arizona , Arkansas California 1,63 2,286 3,77 4,0,600 6,002 6,271 6,442 6,471 6,6 6,882 7,072 Colorado Connecticut Delaware District of Columbia Florida 1,013 1,391 2,181 2,77 3,480 3,1 3,72 3,741 3,879 3,800 4,0 4,009 Georgia ,38 1,847 1,902 1,861 1,972 1,890 2,126 2,162 2,240 Hawaii Idaho Illinois 688 1,073 1,30 2,10 2,71 2,696 2,897 2,793 2,814 2,873 3,038 3,109 Indiana ,111 1,141 1,10 1,128 1,129 1,24 1,363 1,299 Iowa Kansas Kentucky Louisiana ,12 1,177 1,261 1,318 1,268 1,287 1,202 1,290 Maine Maryland ,01 1,380 1,316 1,363 1,494 1,3 1,26 1,60 1,17 Massachusetts , ,021 1,098 1,126 1,083 1,109 1,071 Michigan ,093 1,444 1,80 1,91 2,033 2,026 2,12 2,341 2,314 2,276 Minnesota Mississippi Missouri ,048 1,109 1,040 1,120 1,132 1,13 1,188 1,214 Montana Nebraska Nevada New Hampshire New Jersey ,173 1,3 1,801 1,941 1,926 2,006 1,9 2,020 2,066 2,064 New Mexico New York 1,26 1,72 2,93 3,084 3,797 3,782 3,83 3,966 4,108 4,16 4,248 4,23 North Carolina ,2 1,721 1,793 1,817 1,826 1,79 1,918 1,902 1,982 North Dakota Ohio ,421 1,632 2,240 2,229 2,332 2,442 2,360 2,404 2,61 2,69 Oklahoma Oregon Pennsylvania 766 1,27 1,769 2,07 2,606 2,29 2,76 2,90 2,766 2,800 2,944 2,893 Rhode Island South Carolina ,080 1,069 1,027 1,077 South Dakota Tennessee ,092 1,083 1,169 1,123 1,199 1,323 1,310 1,386 Texas 916 1,311 2,09 2,13 3,281 3,4 3,442 3,721 3,761 3,937 4,00 4,164 Utah Vermont Virginia ,19 1,282 1,362 1,02 1,46 1,70 1,29 1,702 1,604 Washington West Virginia Wisconsin ,047 1,00 1,088 1,032 Wyoming American Samoa * * * * * * * * * * * * Guam * * Puerto Rico Saipan. *. * *. * * * * * * Virgin Islands * Foreign * * Unknown All 1,289 21,830 32,709 41,067 2,100 3,62,23 7,033 8,247 9,841 61,668 62,129 pg 446